Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Johnson and Johnson
Cerilliant
Harvard Business School
Julphar
Cantor Fitzgerald
Daiichi Sankyo
Merck
Mallinckrodt

Generated: October 20, 2017

DrugPatentWatch Database Preview

Pharmachemie Bv Company Profile

« Back to Dashboard

What is the competitive landscape for PHARMACHEMIE BV, and what generic and branded alternatives to PHARMACHEMIE BV drugs are available?

PHARMACHEMIE BV has eight approved drugs.



Summary for Applicant: Pharmachemie Bv

US Patents:0
Tradenames:6
Ingredients:6
NDAs:8
Drug Master File Entries: (click here to view)2
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077679-002Feb 25, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077269-003Oct 14, 2004APRXNoYes► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
METHOTREXATE SODIUM PRESERVATIVE FREE
methotrexate sodium
INJECTABLE;INJECTION040843-003Feb 27, 2012APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077269-001Oct 14, 2004APRXNoYes► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
BLEOMYCIN SULFATE
bleomycin sulfate
INJECTABLE;INJECTION065201-001Dec 13, 2007DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063336-004Feb 28, 1995APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CISPLATIN
cisplatin
INJECTABLE;INJECTION074656-001May 16, 2000APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-002May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
CARBOPLATIN
carboplatin
INJECTABLE;IV (INFUSION)077679-001Feb 25, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmachemie Bv
DOXORUBICIN HYDROCHLORIDE
doxorubicin hydrochloride
INJECTABLE;INJECTION063097-001May 21, 1990APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Colorcon
Daiichi Sankyo
Queensland Health
Healthtrust
Merck
US Army
Johnson and Johnson
Fuji
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot